Membership

Newsletters

November 2016 Newsletter

With the recent presentation of the data from Keynote-024, and the recent approval of pembrolizumab for high PD-L1 expressing tumors, the landscape of lung cancer oncology will change dramatically and for the better.

October 2016 Newsletter

Your IASLC has just partnered with the Chinese Society of Clinical Oncology (CSCO), chaired by IASLC Board of Directors member Yi-Long Wu, to present a joint IASLC-CSCO symposium.

September 2016 Newsletter

As I write this, we are in the midst of a successful Olympic games held in Rio de Janeiro, and looking forward to the IASLC's 7th Latin American Conference on Lung Cancer (LALCA).

August 2016 Newsletter

Every day I spend in my lung cancer clinic I see happy and sad stories.

July 2016 Newsletter

With the recent announcement that a first-line immunotherapy trial for non-small cell lung cancer (NSCLC) is positive for survival improvement, I can see the standard of care for lung cancer patients radically changing over the next few years.

June 2016 Newsletter

IASLC‘s Asia Pacific Lung Cancer Conference (APLCC) was held in mid-May in beautiful Chiang Mai, Thailand.

Pages